Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer’s disease. Lancet. 2021;397:1577–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14:32.

Article  PubMed  PubMed Central  Google Scholar 

Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007;68:1718–25.

Article  CAS  PubMed  Google Scholar 

Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011;46:399–424.

Article  PubMed  PubMed Central  Google Scholar 

Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–19.

Article  CAS  PubMed  Google Scholar 

Morris E, Chalkidou A, Hammers A, Peacock J, Summers J, Keevil S. Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2016;43:374–85.

Article  CAS  PubMed  Google Scholar 

Villemagne VL, Rowe CC. Amyloid PET Ligands for Dementia. PET Clin. 2010;5:33–53.

Article  PubMed  Google Scholar 

Byun BH, Kim BI, Park SY, Ko IO, Lee KC, Kim KM, et al. Head-to-head comparison of 11C-PiB and 18F-FC119S for Abeta imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer’s disease patients. Medicine (Baltimore). 2017;96:e6441.

Article  PubMed  Google Scholar 

Lee BS, Chu SY, Kwon HR, Park C, Sirion U, Brockschnieder D, et al. Synthesis and evaluation of 6-(3-[(18)F]fluoro-2-hydroxypropyl)-substituted 2-pyridylbenzothiophenes and 2-pyridylbenzothiazoles as potential PET tracers for imaging Abeta plaques. Bioorg Med Chem. 2016;24:2043–52.

Article  CAS  PubMed  Google Scholar 

Lee I, Na HR, Byun BH, Lim I, Kim BI, Choi CW, et al. Clinical usefulness of 18F-FC119S positron-emission tomography as an auxiliary diagnostic method for dementia: an open-label, single-dose. Evaluator-Blind Clinical Trial J Clin Neurol. 2020;16:131–9.

PubMed  Google Scholar 

Bucci M, Savitcheva I, Farrar G, Salvado G, Collij L, Dore V, et al. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [(18)F]flutemetamol amyloid PET images. Eur J Nucl Med Mol Imaging. 2021;48:2183–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuszynski T, Rullmann M, Luthardt J, Butzke D, Tiepolt S, Gertz HJ, et al. Evaluation of software tools for automated identification of neuroanatomical structures in quantitative beta-amyloid PET imaging to diagnose Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2016;43:1077–87.

Article  CAS  PubMed  Google Scholar 

Benvenutto A, Giusiano B, Koric L, Gueriot C, Didic M, Felician O, et al. Imaging biomarkers of neurodegeneration in alzheimer’s disease: Distinct contributions of cortical mri atrophy and FDG-PET hypometabolism. J Alzheimers Dis. 2018;65:1147–57.

Article  CAS  PubMed  Google Scholar 

Zaidi H, Ruest T, Schoenahl F, Montandon ML. Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET. Neuroimage. 2006;32:1591–607.

Article  PubMed  Google Scholar 

Baik K, Jeon S, Park M, Lee YG, Lee PH, Sohn YH, et al. Comparison between (18)F-Florapronol and (18)F-Florbetaben imaging in patients with cognitive impairment. J Clin Neurol. 2023;19:260–9.

Article  PubMed  PubMed Central  Google Scholar 

Paghera B, Altomare D, Peli A, Morbelli S, Buschiazzo A, Bauckneht M, et al. Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability? Q J Nucl Med Mol Imaging. 2020;64:414–21.

Article  PubMed  Google Scholar 

Collij LE, Salvado G, Shekari M, Lopes Alves I, Reimand J, Wink AM, et al. Visual assessment of [(18)F]flutemetamol PET images can detect early amyloid pathology and grade its extent. Eur J Nucl Med Mol Imaging. 2021;48:2169–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee J, Ha S, Kim REY, Lee M, Kim D, Lim HK. Development of amyloid PET analysis pipeline using deep learning-based brain MRI segmentation-A comparative validation study. Diagnostics (Basel). 2022;12(3):623.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim S, Wang SM, Kang DW, Um YH, Han EJ, Park SY, et al. A Comparative analysis of two automated quantification methods for regional cerebral amyloid retention: PET-Only and PET-and-MRI-based methods. Int J Mol Sci. 2024;25(14):7649.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology. 1984;34:939–44.

Article  CAS  PubMed  Google Scholar 

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

Article  CAS  PubMed  Google Scholar 

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: a report of the amyloid imaging task force, the society of nuclear medicine and molecular imaging, and the Alzheimer’s association. Alzheimers Dement. 2013;9:E1–16.

Article  Google Scholar 

Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015;313:1924–38.

Article  PubMed  PubMed Central  Google Scholar 

Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.

Article  CAS  PubMed  Google Scholar 

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.

Article  CAS  PubMed  Google Scholar 

Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer’s disease. Alzheimers Dement. 2017;13:205–16.

Article  PubMed  Google Scholar 

Lowe VJ, Lundt ES, Senjem ML, Schwarz CG, Min HK, Przybelski SA, et al. White matter reference region in PET Studies of (11)C-Pittsburgh compound B uptake: Effects of age and amyloid-beta deposition. J Nucl Med. 2018;59:1583–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li K, Rashid T, Li J, Honnorat N, Nirmala AB, Fadaee E, et al. Postmortem brain imaging in Alzheimer’s disease and related dementias: the south Texas Alzheimer’s disease research center repository. J Alzheimers Dis. 2023;96:1267–83.

Article  CAS  PubMed  PubMed Central  Google Scholar